Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

AI Biotech, BioXcel Therapeutics, Files for $69M IPO

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace

Continue ReadingAI Biotech, BioXcel Therapeutics, Files for $69M IPO

Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace

Continue ReadingPurdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis

Walgreens Makes a Takeover Play for Drug Distributor AmerisourceBergen

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

AmerisourceBergen is one of the biggest drug distributors in the U.S. Source: BioSpace

Continue ReadingWalgreens Makes a Takeover Play for Drug Distributor AmerisourceBergen

3 Biotech Gems to Stock Up on This Month

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

A look at a few bargains in today's choppy market. Source: BioSpace

Continue Reading3 Biotech Gems to Stock Up on This Month

Amicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

Amicus announced that the FDA accepted its NDA for migalastat to treat Fabry disease in patients with amenable mutations. Source: BioSpace

Continue ReadingAmicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date

Ramaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

With the deal in hand, Roivant has stepped into the world of metabolic diseases. Source: BioSpace

Continue ReadingRamaswamy's Roivant Inks $650M R&D Deal With This Tiny Diabetes Biotech

Biotech Startup Rubius to Double Footprint With New Kendall Square Lease

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property. Source: BioSpace

Continue ReadingBiotech Startup Rubius to Double Footprint With New Kendall Square Lease

Cambridge's Surface Oncology Promotes CBO to Top Job

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

Mr. Goater succeeds interim chief executive officer Dan Lynch, who will remain executive chairman of Surface’s board of directors. Source: BioSpace

Continue ReadingCambridge's Surface Oncology Promotes CBO to Top Job

Genentech Shows Off New Mid-Stage DME Data

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

The study assessed two doses of RG7716 versus ranibizumab standard of care given as monthly intravitreal injections. Source: BioSpace

Continue ReadingGenentech Shows Off New Mid-Stage DME Data

Axovant CEO David Hung Abruptly Exits, COO and Several Directors Also Resign

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

Axovant shares plunged after Hung abruptly resigned as CEO and also stepped down from his seat on the company board of directors. Source: BioSpace

Continue ReadingAxovant CEO David Hung Abruptly Exits, COO and Several Directors Also Resign
  • Go to the previous page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.